GR1002731B - Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες. - Google Patents

Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες.

Info

Publication number
GR1002731B
GR1002731B GR960100360A GR960100360A GR1002731B GR 1002731 B GR1002731 B GR 1002731B GR 960100360 A GR960100360 A GR 960100360A GR 960100360 A GR960100360 A GR 960100360A GR 1002731 B GR1002731 B GR 1002731B
Authority
GR
Greece
Prior art keywords
paracetamol
active ingredients
solutions containing
containing combinations
medicinal solutions
Prior art date
Application number
GR960100360A
Other languages
English (en)
Inventor
Original Assignee
Uni-Pharma ����� ������ �.�.�.�. ������������ ����������
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni-Pharma ����� ������ �.�.�.�. ������������ ���������� filed Critical Uni-Pharma ����� ������ �.�.�.�. ������������ ����������
Publication of GR1002731B publication Critical patent/GR1002731B/el

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR960100360A 1996-10-21 1996-10-21 Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες. GR1002731B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR96100360 1996-10-21

Publications (1)

Publication Number Publication Date
GR1002731B true GR1002731B (el) 1997-07-04

Family

ID=10942524

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960100360A GR1002731B (el) 1996-10-21 1996-10-21 Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες.

Country Status (1)

Country Link
GR (1) GR1002731B (el)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916347A1 (en) * 1997-11-18 1999-05-19 Uni-Pharma Kleon Tsetis A.B.E.E., Farmakeftika Ergastiria Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances
WO2001068069A2 (en) * 2000-03-15 2001-09-20 King's College London Pharmaceutical composition comprising paracetamol
WO2007024311A1 (en) * 2005-08-24 2007-03-01 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
EP2094253A1 (en) * 2006-12-09 2009-09-02 Eric M. Soderling Acetaminophen compositions having minimized side effects including reduced hepatotoxicity
EP2596112A1 (en) * 2010-07-21 2013-05-29 Cumberland Pharmaceuticals Inc. Acetycysteine compositions and methods of use thereof
AU2011202871B2 (en) * 2005-08-24 2014-06-12 Cumberland Pharmaceuticals Inc. Acetylcysteine composition and uses therefor

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916347A1 (en) * 1997-11-18 1999-05-19 Uni-Pharma Kleon Tsetis A.B.E.E., Farmakeftika Ergastiria Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances
EP1285667A2 (en) * 1997-11-18 2003-02-26 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances
EP1285667A3 (en) * 1997-11-18 2003-03-26 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances
WO2001068069A2 (en) * 2000-03-15 2001-09-20 King's College London Pharmaceutical composition comprising paracetamol
WO2001068069A3 (en) * 2000-03-15 2002-04-11 King S College London Pharmaceutical composition comprising paracetamol
US8148356B2 (en) 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
AU2006282030B2 (en) * 2005-08-24 2011-07-07 Cumberland Pharmaceuticals Inc. Acetylcysteine composition and uses therefor
WO2007024311A1 (en) * 2005-08-24 2007-03-01 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
AU2011202871B2 (en) * 2005-08-24 2014-06-12 Cumberland Pharmaceuticals Inc. Acetylcysteine composition and uses therefor
EP2094253A1 (en) * 2006-12-09 2009-09-02 Eric M. Soderling Acetaminophen compositions having minimized side effects including reduced hepatotoxicity
EP2094253A4 (en) * 2006-12-09 2010-02-10 Eric M Soderling PARACETAMOL COMPOSITIONS WITH REDUCED ADVERSE EFFECTS, INCLUDING REDUCED HEPATOTOXICITY
EP2596112A1 (en) * 2010-07-21 2013-05-29 Cumberland Pharmaceuticals Inc. Acetycysteine compositions and methods of use thereof
EP2596112A4 (en) * 2010-07-21 2015-01-21 Cumberland Pharmaceuticals Inc ACETYCYSTEIN COMPOSITIONS AND USE METHOD THEREFOR
US9327028B2 (en) 2010-07-21 2016-05-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
IE882960L (en) Osmotic dosage form for administering isradipine
KR880009662A (ko) Igf-ii함유 약제
GB2062465B (en) Topical preparation containing nitroglycerine and optionally other medicaments
DK0851753T3 (da) Aerosolpræparater
JPS6490123A (en) Nitroglycerol spray agent
ES2183841T3 (es) Formas de dosificacion para administrar un farmasco en una formulacion lquidid.
ES2172655T3 (es) Formas galenicas estables al almacenamiento.
AR021922A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos, budesonido y formoterol.
JPS51148013A (en) Stable insulin preparation for nosal administration
KR860000865A (ko) 약제 제형의 제조방법
ES460743A1 (es) Procedimiento para la obtencion de preparados medicinales con ph acido.
AR021921A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos y budesonido.
GR1002731B (el) Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες.
NZ237513A (en) Retinoic acid esters, preparation and pharmaceutical/cosmetic compositions thereof
JPS53145932A (en) Stable aromatic gel containing perfume
LV11818A (lv) Jauna farmaceitiska kompozicija stabilas pulverveida zalu formas pagatavosanai
EP0170269A3 (en) Medicated cosmetic compositions
WO2002053124A3 (en) Stable skin care compositions containing a retinoid and a retinoid booster system
IT1204777B (it) Composizione per la preparazione estemporanea di formulazioni per applicazioni topiche per uso farmaceutico e cosmetico
JPS5218811A (en) Preparation of aqueous solution of fat- soluble substances
JPS5675423A (en) Physiologically active high polymer substance-containing composition for mucosa administration and its preparation
JPS55122724A (en) Antidiabetic agent
JPS5762221A (en) Embrocation for external use
JPS5762220A (en) Embrocation for external use
JPS57144214A (en) Pharmaceutical preparation for rectum medication

Legal Events

Date Code Title Description
MA Right expired

Effective date: 20161022